Literature DB >> 16330780

Huntington's disease and neurogenesis: FGF-2 to the rescue?

Albert R La Spada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16330780      PMCID： PMC1312425          DOI： 10.1073/pnas.0509222102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

Review 2.  Molecular manipulation of neural precursors in situ: induction of adult cortical neurogenesis.

Authors:  Paola Arlotta; Sanjay S Magavi; Jeffrey D Macklis
Journal:  Exp Gerontol       Date:  2003 Jan-Feb       Impact factor: 4.032

3.  FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease.

Authors:  Kunlin Jin; Michelle LaFevre-Bernt; Yunjuan Sun; Sylvia Chen; Juliette Gafni; Danielle Crippen; Anna Logvinova; Christopher A Ross; David A Greenberg; Lisa M Ellerby
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.

Authors:  Wen Jiang; Yun Zhang; Lan Xiao; Jamie Van Cleemput; Shao-Ping Ji; Guang Bai; Xia Zhang
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

6.  IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures.

Authors:  K B Bjugstad; W M Zawada; S Goodman; C R Freed
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

7.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain.

Authors:  Maurice A Curtis; Ellen B Penney; Andree G Pearson; Willeke M C van Roon-Mom; Niqi J Butterworth; Michael Dragunow; Bronwen Connor; Richard L M Faull
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

9.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

Review 10.  Toxic proteins in neurodegenerative disease.

Authors:  J Paul Taylor; John Hardy; Kenneth H Fischbeck
Journal:  Science       Date:  2002-06-14       Impact factor: 47.728
View more
  3 in total

Review 1.  Neurotrophic factors in neurodegenerative disorders : potential for therapy.

Authors:  Fabio Fumagalli; Raffaella Molteni; Francesca Calabrese; Paola Francesca Maj; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

2.  Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's disease.

Authors:  Sreedevi Chandrasekaran; Danail Bonchev
Journal:  Comput Struct Biotechnol J       Date:  2016-02-10       Impact factor: 7.271

Review 3.  The endocannabinoid system: a putative role in neurodegenerative diseases.

Authors:  Giuseppe Di Iorio; Matteo Lupi; Fabiola Sarchione; Ilaria Matarazzo; Rita Santacroce; Filippo Petruccelli; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Int J High Risk Behav Addict       Date:  2013-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.